Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major ...
Investing.com -- Intelligent Bio Solutions Inc. (NASDAQ:INBS) stock fell 21.3% in after-hours trading Wednesday following the company’s announcement of a $10 million private placement with two ...
Nuvation Bio enrolled the first patient in a late-stage study of Ibtrozi. The bigger story, though, was a Wall Street analyst's initiation of coverage on the stock. Shares of Nuvation Bio (NYSE: NUVB) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback